Effect of serum sample storage temperature on metabolomic and proteomic biomarkers
Erkka Valo(University of Helsinki), R. Neil Dalton(Evelina London Children's Healthcare), Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Paul McKeigue(Edinburgh Cancer Research), Helen M. Colhoun(Edinburgh Cancer Research), Luke A. K. Blackbourn(Edinburgh Cancer Research), Niina Sandholm(University of Helsinki), Charles Turner(National Health Service), Stuart J. McGurnaghan(University of Edinburgh), Marco Colombo(University of Edinburgh), David B. Dunger(Addenbrooke's Hospital)
Cited by 64
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
|New England Journal of Medicine|2023|2.6k
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
|Nature Genetics|2007|1.5k